Abstract
Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 204-209 |
| Number of pages | 6 |
| Journal | Journal of Otolaryngology of Japan |
| Volume | 119 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jan 1 2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Otorhinolaryngology
Cite this
A case of pneumocystis pneumonia after Cetuximab-based bioradiotherapy. / Shinohara, Asano; Kogo, Ryunosuke; Uryu, Hideoki; Yasumatsu, Ryuji; Nakashima, Torahiko; Komune, Shizuo.
In: Journal of Otolaryngology of Japan, Vol. 119, No. 3, 01.01.2016, p. 204-209.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A case of pneumocystis pneumonia after Cetuximab-based bioradiotherapy
AU - Shinohara, Asano
AU - Kogo, Ryunosuke
AU - Uryu, Hideoki
AU - Yasumatsu, Ryuji
AU - Nakashima, Torahiko
AU - Komune, Shizuo
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.
AB - Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.
UR - http://www.scopus.com/inward/record.url?scp=84964403737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964403737&partnerID=8YFLogxK
U2 - 10.3950/jibiinkoka.119.204
DO - 10.3950/jibiinkoka.119.204
M3 - Article
C2 - 27244906
AN - SCOPUS:84964403737
VL - 119
SP - 204
EP - 209
JO - Journal of Otolaryngology of Japan
JF - Journal of Otolaryngology of Japan
SN - 0030-6622
IS - 3
ER -